Previously, we found that ISL of 10 μM exhibits an inhibitory effect on Vascular endothelial growth factor (VEGF)-induced triple-negative breast cancer migration and invasion through downregulation of the PI3K-AKT-MAPK signaling pathway [23]. The gene discussed is VEGFA; the disease is triple-negative breast carcinoma.